Glenmark Pharmaceuticals has informed about press release titled, 'Glenmark Pharmaceuticals receives ANDA approval for Colesevelam Hydrochloride for Oral Suspension, 1.875 grams/Packet and 3.75 grams/Packet.'.
The above information is a part of company’s filings submitted to BSE.